| NDC Code |
15584-0101-1 |
| Proprietary Name |
Atripla |
| Package Description |
30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (15584-0101-1) |
| Product NDC |
15584-0101 |
| Product Type Name |
HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name |
efavirenz, emtricitabine, and tenofovir disoproxil fumarate |
| Dosage Form Name |
TABLET, FILM COATED |
| Route Name |
ORAL |
| Start Marketing Date |
20060720 |
| Marketing Category Name |
NDA |
| Labeler Name |
Bristol Myers Squibb & Gilead Sciences, LLC |
| Substance Name |
EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE |
| Strength Number |
600; 200; 300 |
| Strength Unit |
mg/1; mg/1; mg/1 |
| Pharmaceutical Classes |
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Non-Nucleoside Analog [Chemical/Ingredient],Non-Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
